Mundipharma Pharmaceuticals Limited - Formerly Napp Laboratories

Targin 5 mg/2.5 mg

Each prolonged-release tablet contains 5 mg of oxycodone hydrochloride equivalent to 4.5 mg oxycodone and 2.5 mg naloxone hydrochloride as 2.73 mg of naloxone hydrochloride dihydrate equivalent to 2.25 mg naloxone.

Each prolonged-release tablet contains 10 mg of oxycodone hydrochloride equivalent to 9 mg oxycodone and 5 mg naloxone hydrochloride as 5.45 mg of naloxone hydrochloride dihydrate equivalent to 4.5 mg naloxone.

Targin 20 mg/10 mg

Each prolonged-release tablet contains 20 mg of oxycodone hydrochloride equivalent to 18 mg oxycodone and 10 mg naloxone hydrochloride as 10.9 mg of naloxone hydrochloride dihydrate equivalent to 9 mg naloxone.

Targin 40 mg/20 mg

Each prolonged-release tablet contains 40 mg of oxycodone hydrochloride equivalent to 36 mg oxycodone and 20 mg naloxone hydrochloride as 21.8 mg of naloxone hydrochloride dihydrate equivalent to 18 mg naloxone.

Excipient with known effect: